We showed that Tlr9–/– mice are more resistant to pressure overload than control mice, and inhibitory ODN to TLR9 (ODN2088) improved survival in TAC-operated wild-type mice when administered before TAC (7). The gene discussed is TLR9; the disease is persistent truncus arteriosus.